Heather Raymon

Affiliations

Celgene Corporation, Department of Pharmacology, San Diego, CA, USA.

Publications (2)

First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy.

Cancer management and research

Avec: Pamela Munster , Monica Mita , Amit Mahipal , John Nemunaitis , Christophe Massard , Tom Mikkelsen , Cristina Cruz , Luis Paz-Ares , Manuel Hidalgo , Dana Rathkopf , George Blumenschein , David C Smith , Barbara Eichhorst , Tim Cloughesy , Ellen H Filvaroff , Shaoyi Li , Heather Raymon , Hans de Haan , Kristen Hege , Johanna C Bendell

Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes.

Annals of hematology

Avec: Amer M Zeidan , Daniel J DeAngelo , Jeanne Palmer , Christopher S Seet , Martin S Tallman , Xin Wei , Heather Raymon , Priya Sriraman , Stephan Kopytek , Jan Philipp Bewersdorf , Michael R Burgess , Kristen Hege , Wendy Stock

Réseau de co-auteurs

Kristen Hege 2 collaborations

Pamela Munster 1 collaboration

Monica Mita 1 collaboration

Amit Mahipal 1 collaboration

John Nemunaitis 1 collaboration

Christophe Massard 1 collaboration

Tom Mikkelsen 1 collaboration

Cristina Cruz 1 collaboration

Luis Paz-Ares 1 collaboration

Manuel Hidalgo 1 collaboration

Dana Rathkopf 1 collaboration

George Blumenschein 1 collaboration

David C Smith 1 collaboration

Barbara Eichhorst 1 collaboration

Tim Cloughesy 1 collaboration

Ellen H Filvaroff 1 collaboration

Shaoyi Li 1 collaboration

Hans de Haan 1 collaboration

Johanna C Bendell 1 collaboration

Amer M Zeidan 1 collaboration

Daniel J DeAngelo 1 collaboration

Jeanne Palmer 1 collaboration

Christopher S Seet 1 collaboration

Martin S Tallman 1 collaboration

Xin Wei 1 collaboration

Priya Sriraman 1 collaboration

Stephan Kopytek 1 collaboration

Jan Philipp Bewersdorf 1 collaboration

Michael R Burgess 1 collaboration

Wendy Stock 1 collaboration